IFP Advisors’s First Tracks Biotherapeutics TRAX Stock Holding History

IFP Advisors’s Portfolio TRAX Stock Details TRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20	Buy	+1	New	+$19	﹤0.01%	5077

Other funds holding TRAX

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

IFP Advisors's TRAX Position: Q2 2026 in Review

IFP Advisors opened a new position in First Tracks Biotherapeutics (TRAX) in Q2 2026: 1 share worth $20. The stake represents ﹤0.01% of the portfolio and ranks #5077 among its holdings.

16 funds tracked by Wall St. Rank hold TRAX as of Q2 2026.

IFP Advisors held 1 share of First Tracks Biotherapeutics worth $20 as of Q2 2026.
First Tracks Biotherapeutics was a new IFP Advisors position in Q2 2026.
First Tracks Biotherapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5077 holding.
16 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.